Title:
BIOMARKER AND DETECTION METHOD FOR DETECTING RISK OF CANCER RECURRENCE
Document Type and Number:
WIPO Patent Application WO/2019/237641
Kind Code:
A1
Abstract:
Disclosed by the present invention are a biomarker and a detection method for detecting the risk of cancer recurrence. The biomarker at least comprises one of the following genes: SLCO2A1, CGNL1, SUPV3L1, TATDN2, MGAT4B, VAV2, SLC25A33, MCCC1, ASNS, CASKIN1, DNMT3B, AURKA, OIP5, CTHRC1 and GOLGA7B.
Inventors:
TANG DAMU (CN)
HE LIZHI (CN)
CHEN ZHENG (CN)
CHEN JING (CN)
ZHAO KUNCHENG (CN)
ZHAO FENGJUAN (CN)
ZENG YONGKE (CN)
MA JINGXIANG (CN)
HE LIZHI (CN)
CHEN ZHENG (CN)
CHEN JING (CN)
ZHAO KUNCHENG (CN)
ZHAO FENGJUAN (CN)
ZENG YONGKE (CN)
MA JINGXIANG (CN)
Application Number:
PCT/CN2018/113414
Publication Date:
December 19, 2019
Filing Date:
November 01, 2018
Export Citation:
Assignee:
SHENZHEN YIKANG BIOTECHNOLOGY CO LTD (CN)
International Classes:
C12Q1/68
Foreign References:
| CN108424970A | 2018-08-21 |
Other References:
GAO, J. ET AL.: "Intergrative analysis of complex cancer genomics and clinical profiles using cBioPortal", SCI SIGNAL, vol. 6, no. 269, 2 April 2013 (2013-04-02), XP055297746, DOI: 10.1126/scisignal.2004088
LIN, X. ET AL.: "Overexpression of MUC1 and genomic alterations in its network associate with prostate cancer progression", NEOPLASIA, vol. 19, no. 11, 18 September 2017 (2017-09-18), pages 857 - 867, XP055670259
YANG, L: "Development and validation of a 28- gene hypoxia-related prognostic signature for localized prostate cancer", EBIOMEDICINE, vol. 31, 23 April 2018 (2018-04-23), pages 182 - 189, XP055670266, DOI: 10.1016/j.ebiom.2018.04.019
LIN, X. ET AL.: "Overexpression of MUC1 and genomic alterations in its network associate with prostate cancer progression", NEOPLASIA, vol. 19, no. 11, 18 September 2017 (2017-09-18), pages 857 - 867, XP055670259
YANG, L: "Development and validation of a 28- gene hypoxia-related prognostic signature for localized prostate cancer", EBIOMEDICINE, vol. 31, 23 April 2018 (2018-04-23), pages 182 - 189, XP055670266, DOI: 10.1016/j.ebiom.2018.04.019
Attorney, Agent or Firm:
BORSAM INTELLECTUAL PROPERTY (CN)
Download PDF: